Persistent HIV Incidence Among Injection Drug Users in San Francisco During the 1990s: Results of Five Studies
- 1 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 37 (5) , 1667-1669
- https://doi.org/10.1097/00126334-200412150-00025
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987-1998American Journal of Epidemiology, 2003
- Prevalence and Correlates of HIV Infection Among Young Injection Drug Users in San FranciscoJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Hepatitis C Virus Seroconversion among Young Injection Drug Users: Relationships and RisksThe Journal of Infectious Diseases, 2002
- Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.American Journal of Epidemiology, 2002
- Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion.American Journal of Epidemiology, 2001
- Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysisThe Lancet, 2001
- Low Estimates of HIV Seroconversions Among Clients of a Drug Treatment Clinic in San Francisco, 1995 to 1998JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemicAmerican Journal of Public Health, 2000
- Detection of Early HIV Infection and Estimation of Incidence Using a Sensitive/Less-Sensitive Enzyme Immunoassay Testing Strategy at Anonymous Counseling and Testing Sites in San FranciscoJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention PurposesJAMA, 1998